TFC Financial Management’s Catalyst Pharmaceutical CPRX Stock Holding History

TFC Financial Management’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-6	Closed	-$189	–	1059
2026 Q2	$189	Hold	6	–	–	﹤0.01%	846
2026 Q1	$149	Hold	6	–	–	﹤0.01%	822
2025 Q4	$141	Buy	+6	New	+$134	﹤0.01%	818

Other funds holding CPRX

Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

TFC Financial Management's CPRX Position: Q3 2026 in Review

TFC Financial Management sold out of Catalyst Pharmaceutical (CPRX) in Q3 2026, closing a stake of 6 shares — an estimated $189 sold.

TFC Financial Management first reported a position in CPRX in Q4 2025 and held it in 3 quarters. The position peaked at $189 in Q2 2026. 2 funds tracked by Wall St. Rank hold CPRX as of Q3 2026.

TFC Financial Management reported no remaining Catalyst Pharmaceutical position as of Q3 2026 after selling out during the quarter.
TFC Financial Management sold 6 Catalyst Pharmaceutical shares in Q3 2026, an estimated $189.
TFC Financial Management first reported a position in Catalyst Pharmaceutical in Q4 2025 and held it in 3 quarters.
TFC Financial Management's Catalyst Pharmaceutical position peaked at $189 in Q2 2026.
2 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2026.

Based on TFC Financial Management's 13F filing for Q3 2026, filed 26 Oct 2026.